Prognosis
Based on series of 270 patients, the five year survival by stage was:
- T1 – 86 percent
- T2 – 86 percent
- T3 – 60 percent
- T4 – 45 percent
- N0 – 76 percent
- Node-positive – 54 percent
Read more about this topic: Anal Cancer
Prognosis
Based on series of 270 patients, the five year survival by stage was:
Read more about this topic: Anal Cancer